Mast cell mediator release pathway

The **mast cell mediator release pathway** refers to the sequence of cellular events by which mast cells—innate immune cells found throughout connective tissues—release various bioactive substances in response to stimuli. Upon activation (most classically via IgE crosslinking at FcεRI receptors), mast cells rapidly exocytose preformed granule contents such as histamine, tryptase, heparin, proteases, and cytokines into surrounding tissues[1][2][3][4]. This process is known as degranulation. Additionally, they synthesize and secrete lipid mediators like prostaglandins and leukotrienes. These mediators play central roles in immediate allergic reactions (e.g., urticaria/angioedema/anaphylaxis), inflammation amplification through recruitment of other immune cells (eosinophils/basophils/neutrophils/lymphocytes), vascular permeability increase leading to edema/redness/pruritus/pain[1][3][4], tissue repair processes, host defense against pathogens including parasites/bacteria/viruses[2], and homeostatic responses. Mast cells can be activated by both IgE-dependent mechanisms (allergens) and non-IgE triggers such as complement proteins, microbial products via Toll-like receptors (TLRs), physical stimuli or certain drugs/hormones/cytokines[1][2][4]. Dysregulation or inappropriate activation underlies conditions like anaphylaxis or chronic inflammatory diseases. Note: The "mast cell mediator release pathway" is a biological process/pathway—not a single molecular target/receptor/enzyme/transporter—and thus does not fit standard therapeutic target classification schemes.

Other names

Mast cell degranulation pathwayMast cell activation and mediator releaseMast cell secretory pathway

Mechanisms of action for drugs in this context include inhibition of mast cell degranulation, blockade of released mediators such as histamine receptors, inhibition of downstream signaling pathways.